89Zr-DFO-girentuximab Expanded Access Program (EAP)

Conditions: Clear Cell Renal Cell Carcinoma Interventions: Diagnostic Test: 89Zr-DFO-girentuximab Sponsors: Telix International Pty Ltd Available
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials